HARP
COM:HARPOONTX
Harpoon Therapeutics, Inc.
- Stock
Last Close
22.99
08/03 21:00
Market Cap
865.08M
Beta: -
Volume Today
6.40M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
net income | -11.41M - | -16.83M 47.55% | -27.37M 62.60% | -55.57M 103.07% | -49.91M 10.19% | -116.72M 133.87% | -67.73M 41.97% | |
depreciation and amortization | 198K - | 366K 84.85% | 644K 75.96% | 900K 39.75% | 2.08M 131.33% | 2.19M 5.19% | 2.36M 7.63% | |
deferred income tax | 4K - | -541K - | 491K 190.76% | 2.37M 382.48% | ||||
stock based compensation | 99K - | 367K 270.71% | 672K 83.11% | 2.07M 208.18% | 4.86M 134.67% | 9.46M 94.69% | 8.64M 8.73% | |
change in working capital | 50K - | 17.53M 34,952% | -1.08M 106.14% | 49.05M 4,658.46% | 33.43M 31.85% | -19.91M 159.56% | -33.58M 68.65% | |
accounts receivables | ||||||||
inventory | ||||||||
accounts payables | 570K - | 804K 41.05% | 2.56M 217.79% | -1.76M 168.92% | -1.23M 30.27% | 542K 144.14% | 2.05M 277.68% | |
other working capital | -520K - | 16.72M 3,315.77% | -3.63M 121.71% | 50.81M 1,499.34% | 34.66M 31.79% | -20.45M 159.02% | -35.63M 74.19% | |
other non cash items | 261K - | 285K 9.20% | 1.20M - | 432K 64.06% | 456K 5.56% | 1.13M 148.68% | ||
net cash provided by operating activities | -10.79M - | 1.71M 115.88% | -27.13M 1,682.61% | -2.89M 89.34% | -8.62M 198.03% | -122.15M 1,317.76% | -89.18M 26.99% | |
investments in property plant and equipment | -553K - | -2.27M 311.39% | -663K 70.86% | -3.52M 430.32% | -683K 80.57% | -100K 85.36% | -347K 247.00% | |
acquisitions net | -89.74M - | |||||||
purchases of investments | -141.82M - | -202.18M 42.57% | -151.97M 24.84% | -24.43M 83.93% | ||||
sales maturities of investments | 76.02M - | 139.24M 83.17% | 186.42M 33.88% | 114.51M 38.57% | ||||
other investing activites | 6.75M - | 89.74M - | ||||||
net cash used for investing activites | -553K - | 4.47M 909.22% | -663K 114.82% | -69.31M 10,354.75% | -63.63M 8.21% | 34.35M 153.99% | 89.74M 161.21% | |
debt repayment | ||||||||
common stock issued | 2K - | 89.83M 4,491,300% | 70.65M 21.35% | 3.03M 95.71% | 110.35M 3,539.48% | 5.38M 95.12% | ||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 9.98M - | 22.25M 122.80% | -1.50M 106.75% | 803K 153.46% | 1.64M 104.73% | 1.17M 28.59% | 990K 15.67% | |
net cash used provided by financing activities | 9.98M - | 22.25M 122.82% | 88.33M 296.99% | 71.45M 19.11% | 4.68M 93.46% | 111.52M 2,285.01% | 6.37M 94.29% | |
effect of forex changes on cash | ||||||||
net change in cash | -1.36M - | 28.44M 2,187.96% | 60.54M 112.87% | -757K 101.25% | -67.57M 8,825.50% | 23.72M 135.11% | 6.93M 70.80% | |
cash at beginning of period | 2.35M - | 985K 58.03% | 29.42M 2,887.11% | 89.96M 205.75% | 89.20M 0.84% | 21.64M 75.74% | 45.36M 109.64% | |
cash at end of period | 985K - | 29.42M 2,887.11% | 89.96M 205.75% | 89.20M 0.84% | 21.64M 75.74% | 45.36M 109.64% | 52.29M 15.27% | |
operating cash flow | -10.79M - | 1.71M 115.88% | -27.13M 1,682.61% | -2.89M 89.34% | -8.62M 198.03% | -122.15M 1,317.76% | -89.18M 26.99% | |
capital expenditure | -553K - | -2.27M 311.39% | -663K 70.86% | -3.52M 430.32% | -683K 80.57% | -100K 85.36% | -347K 247.00% | |
free cash flow | -11.35M - | -561K 95.06% | -27.79M 4,853.48% | -6.41M 76.94% | -9.30M 45.14% | -122.25M 1,214.70% | -89.53M 26.77% |
All numbers in USD (except ratios and percentages)